REFERENCES
1. Chakrabarti A, Denning DW, Ferguson BJ, et al. Fungal rhinosinusitis.The Laryngoscope . 2009;119(9):1809-1818.
2. Wingard JR, Hsu J, Hiemenz JW. Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology.Infect Dis Clin . 2010;24(2):257-272.
3. Park AH, Muntz HR, Smith ME, Afify Z, Pysher T, Pavia A. Pediatric Invasive Fungal Rhinosinusitis in Immunocompromised Children With Cancer. Otolaryngol Neck Surg . 2005;133(3):411-416.
4. Ritter A, Fischer S, Yaniv E, et al. Acute Rhinosinusitis in Immunosuppressed Children.
5. Ghadiali MT, Deckard NA, Farooq U, Astor F, Robinson P, Casiano RR. Frozen-Section Biopsy Analysis for Acute Invasive Fungal Rhinosinusitis.Otolaryngol Neck Surg . 2007;136(5):714-719.
6. Costa C, Costa J-M, Desterke C, Botterel F, Cordonnier C, Bretagne S. Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis. J Clin Microbiol . 2002;40(6):2224-2227.
7. Landlinger C, Preuner S, Bašková L, et al. Diagnosis of invasive fungal infections by a real-time panfungal PCR assay in immunocompromised pediatric patients. Leukemia . 2010;24(12):2032-2038.
8. Zhao Z, Li L, Wan Z, Chen W, Liu H, Li R. Simultaneous detection and identification of Aspergillus and mucorales species in tissues collected from patients with fungal rhinosinusitis. J Clin Microbiol . 2011;49(4):1501-1507.
9. Vehreschild JJ, Birtel A, Vehreschild MJGT, et al. Mucormycosis treated with posaconazole: review of 96 case reports. Crit Rev Microbiol . 2013;39(3):310-324.
10. Spellberg B, Ibrahim AS. Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep . 2010;12(6):423-429.
11. Valera FCP, do Lago T, Tamashiro E, Yassuda CC, Silveira F, Anselmo-Lima WT. Prognosis of acute invasive fungal rhinosinusitis related to underlying disease. Int J Infect Dis IJID Off Publ Int Soc Infect Dis . 2011;15(12):e841-844.
12. Turner JH, Soudry E, Nayak JV, Hwang PH. Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence. The Laryngoscope . 2013;123(5):1112-1118.
13. Ba T, Dw K. Thirty years of endoscopic sinus surgery: What have we learned? World J Otorhinolaryngol - Head Neck Surg . 2017;3(2):115-121.
14. Groll AH, Castagnola E, Cesaro S, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol . 2014;15(8):e327-340.
15. Tissot F, Agrawal S, Pagano L, et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients.Haematologica . 2017;102(3):433-444.
16. Johnson PJ, Lydiatt WM, Huerter JV, et al. Invasive Fungal Sinusitis following Liver or Bone Marrow Transplantation. Am J Rhinol . 1994;8(2):77-84.
17. Silveira MLC, Anselmo-Lima WT, Faria FM, et al. Impact of early detection of acute invasive fungal rhinosinusitis in immunocompromised patients. BMC Infect Dis . 2019;19(1):310.
18. Roxbury CR, Smith DF, Higgins TS, et al. Complete surgical resection and short-term survival in acute invasive fungal rhinosinusitis.Am J Rhinol Allergy . 2017;31(2):109-116.
19. Eliashar R, Resnick IB, Goldfarb A, Wohlgelernter J, Gross M. Endoscopic Surgery for Sinonasal Invasive Aspergillosis in Bone Marrow Transplantation Patients. The Laryngoscope . 2007;117(1):78-81.
20. Tarkan O, Karagün B, Ozdemir S, et al. Endonasal treatment of acute invasive fungal rhinosinusitis in immunocompromised pediatric hematology-oncology patients. Int J Pediatr Otorhinolaryngol . 2012;76(10):1458-1464.
21. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol . 2003;119(6):854-858.
22. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis . 2008;46(12):1813-1821.
23. Hamill RJ. Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs . 2013;73(9):919-934.
24. Botero Aguirre JP, Restrepo Hamid AM. Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function.Cochrane Database Syst Rev . 2015;(11):CD010481.
25. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med . 2002;347(6):408-415.
Table 1. Baseline characteristics of the study population